Steward Partners Investment Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Steward Partners Investment Advisory's PPH Position: Q1 2026 in Review
Steward Partners Investment Advisory held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 1,473 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #2152.
Steward Partners Investment Advisory first reported a position in PPH in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.88M in Q4 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Steward Partners Investment Advisory held 1,473 shares of VanEck Pharmaceutical ETF worth $153K as of Q1 2026.
- Steward Partners Investment Advisory left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2152 holding.
- Steward Partners Investment Advisory first reported a position in VanEck Pharmaceutical ETF in Q3 2020 and has held it in 23 quarters since.
- Steward Partners Investment Advisory's VanEck Pharmaceutical ETF position peaked at $1.88M in Q4 2024.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.